Business
RSU vesting for employees
RSU vesting for employees.

About this update from Renalytix Plc
[{"type":"text","content":"\n\n \nRenalytix plc\n(\"Renalytix\" or the \"Company\")\n \nRSU vesting for employees\n \nLONDON and SALT LAKE CITY, August 3, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that 92,770 Restricted Stock Units (\"RSUs\") previously granted to Company employees and consultants in accordance with the Renalytix plc 2020 Equity Incentive Plan have vested. Each RSU is convertible into two ordinary shares of £0.0025 each in the capital of the Company (\"Ordinary Share\") or into one American Depositary Share of the Company (\"ADS\"). Each RSU is to be delivered as an ADS to the relevant employees and consultants.\n \nAn application has been made to the London Stock Exchange for 185,540 new Ordinary Shares to be admitted to trading on AIM. It is expected that admission of the 185,540 new Ordinary Shares to trading on AIM will become effective on, or around, 8am UK time tomorrow 4 August 2023 (\"Admission\"). The new Ordinary Shares will rank pari passu with the existing Ordinary Shares of the Company.\n \nTotal voting rights\n \nFollowing Admission, the Company will have 95,019,440 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 95,019,440.\n \n \nFor further information, please contact:\n \n\n\n\nRenalytix plc\n\n\nwww.renalytix.com\n\n\n\n\nJames McCullough, CEO\n\n\nVia Walbrook PR\n\n\n\n\n\n\n\n \n\n\n\n\nStifel (Nominated Adviser, Joint Broker)\n\n\nTel: 020 7710 7600\n\n\n\n\nAlex Price / Nicholas Moore / Nick Harland / Samira Essebiyea\n\n\n \n\n\n\n\n\n\n\n \n\n\n\n\nInvestec Bank plc (Joint Broker)\n\n\nTel: 020 7597 4000\n\n\n\n\nGary Clarence / Shalin Bhamra\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Limited\n\n\nTel: 020 7933 8780 or [email protected]\n\n\n\n\nPaul McManus / Lianne Applegarth / Alice Woodings\n\n\nMob: 07980 541 893 / 07584 391 303 / 07407 804 654\n\n\n\n\n\n\n\n\n\n\n\n\nCapComm Partners\n\n\n\n\n\n\n\nPeter DeNardo\n\n\nTel: 415-389-6400 or [email protected]\n\n\n\n \nAbout Chronic Kidney Disease\nKidney disease is now recognized as a public health epidemic affecting over 850 million peo...